Antioxidant Supplementation in Patients With Kashin-Beck Disease

Clinical Trial ID NCT00376025

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00376025

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999 5.68
2 Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005 2.13
3 Nutritional and health status of Tibetan children living at high altitudes. N Engl J Med 2001 1.68
4 Selenium and endocrine systems. J Endocrinol 2005 1.36
5 Selenium, the thyroid, and the endocrine system. Endocr Rev 2005 1.33
6 Epithelium-specific glutathione peroxidase, Gpx2, is involved in the prevention of intestinal inflammation in selenium-deficient mice. J Nutr 2005 1.15
7 Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr 2003 0.99
8 Kashin-Beck disease--expanding the spectrum of iodine-deficiency disorders. N Engl J Med 1998 0.85
9 Selenium and thyroid function in infants, children and adolescents. Biofactors 2003 0.77
10 Iodine deficiency mitigates growth retardation and osteopenia in selenium-deficient rats. J Nutr 2006 0.75
Next 100